Study Name# Progress
Research payments
$122,368
Through program year 2024, $122,368 in research payments was reported against Study Name# Progress, across 26 payments, paid by Merck Sharp & Dohme Corporation.
- Paid by
- Merck Sharp & Dohme Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $60,358 | 14 |
| 2023 | Research | $62,010 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Regina Lederman Bellevue, WA Named on 1 payment
- Jasmine Sandhu Dyer, IN Named on 1 payment
- Jordan Webb Gainesville, FL Named on 1 payment
- Laura Pall Devengencie Wellington, OH Named on 1 payment
- Richard Stiles Des Plaines, IL Named on 1 payment
- Jordan Hottenstein Leesport, PA Named on 1 payment
- Walter Saxon Dillwyn, VA Named on 1 payment
- Patricia Schweitzer Chicago, IL Named on 1 payment
- Karin Davis Norcross, GA Named on 1 payment
- Lorelei Grise Arlington Heights, IL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.